Evidence map

ReviewGenes & diseases2026

Research progress in metabolic reprogramming and targeting metabolic pathways for clear cell renal cell carcinoma.

Jia-Tao Yao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 42519728